fosaprepitant 150 MG Injection [Emend Injection]
- RxCUI
- 1731082
- RxNorm name
- fosaprepitant 150 MG Injection [Emend Injection]
- Display name
- fosaprepitant 150 MG Injection [Emend Injection]
- Full name
- fosaprepitant 150 MG Injection [Emend Injection]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:56
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EMEND | FOSAPREPITANT DIMEGLUMINE | Merck Sharp & Dohme LLC | 8d66803a-6811-4c29-9c57-e16acfa87f21 | 2026-02-20 | Warnings, Adverse reactions | 1731082 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 44f634f4-b794-4d55-8ab7-037fdef8ff0f | Emend 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [Emend Injection] [SBD] · Emend 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 30 | These highlights do not include all the information needed to use EMEND FOR INJECTION safely and effectively. See full prescribing information for EMEND FOR INJECTION. EMEND (fosaprepitant) for injection, for intravenous use Initial U.S. Approval: 2008 | 20180326 |
| 8d66803a-6811-4c29-9c57-e16acfa87f21 | Emend 150 MG Injection [PSN] · fosaprepitant 150 MG Injection [Emend Injection] [SBD] · Emend 150 MG (as fosaprepitant dimeglumine 245.3 MG) Injection [SY] | 3 | 20 | These highlights do not include all the information needed to use EMEND FOR INJECTION safely and effectively. See full prescribing information for EMEND FOR INJECTION. EMEND ® (fosaprepitant) for injection, for intravenous use Initial U.S. Approval: 2008 | 20260220 |